Table 2.

Systemic therapy administered to patients after PVE before surgical lobectomy.

Age	Gender	Etiology	Chemotherapy Regimen
66	Male	Colorectal cancer	FOLFOX/bevacizumab
44	Female	Colorectal cancer	5FU
39	Female	Colorectal cancer	FOLFIRINOX
55	Female	Colorectal cancer	FOLFOX
40	Male	Colorectal cancer	FOLFOX/bevacizumab, FOLFIRI/cetuximab
50	Male	Colorectal cancer	FOLFOX
61	Female	Colorectal cancer	FOLFOX
51	Male	Colorectal cancer	FOLFIRI, bevacizumab, 5-FU
40	Male	GIST	Sunitinib